Literature DB >> 3871591

Fever-specific changes in central MSH and CRF concentrations.

M Holdeman, O Khorram, W K Samson, J M Lipton.   

Abstract

The concentration of melanocyte-stimulating hormone (melanotropin; MSH) within the septal region of the brain increases during the fever, and septal injections of MSH are antipyretic. Corticotropin-releasing factor (CRF), when injected intracerebroventricularly, is also antipyretic. Using sensitive radioimmunoassays of microdissected tissue extracts, we established the presence of immunoreactive MSH (IRMSH) and CRF (IRCRF) within discrete central nervous system sites of the rabbit. Leukocytic pyrogen-induced fever and hyperthermia due to heat exposure did not alter concentrations of IRMSH or IRCRF in tissue extracted from preoptic-anterior hypothalamic or midbrain central gray regions. However, significantly greater levels of IRMSH were detected in septal extracts of febrile rabbits than in similar extracts from afebrile controls or heat-stressed animals. A significant decrease in IRCRF was detected in paraventricular nucleus extracts from febrile animals compared with extracts from afebrile controls or heat-stressed rabbits. Our results support the hypothesis that these central peptides have a role in temperature control during fever. Since no changes were detected in extracts from hyperthermic rabbits, it appears that changes in concentration of these neuropeptides within particular brain regions are specific to the febrile state and are not caused by elevation of body temperature or by nonspecific stress.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871591     DOI: 10.1152/ajpregu.1985.248.1.R125

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses.

Authors:  S K Sundar; K J Becker; M A Cierpial; M D Carpenter; L A Rankin; S L Fleener; J C Ritchie; P E Simson; J M Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Threshold dose of interleukin-1 beta for induction of an ACTH response is higher than of a febrile response.

Authors:  T Watanabe; A Morimoto; N Murakami
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

Review 3.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

4.  The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.

Authors:  A W Taylor
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

5.  Neuropeptide regulation of interleukin-1 activities. Capacity of alpha-melanocyte stimulating hormone to inhibit interleukin-1-inducible responses in vivo and in vitro exhibits target cell selectivity.

Authors:  B A Robertson; L C Gahring; R A Daynes
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

Review 6.  Applications of the role of α-MSH in ocular immune privilege.

Authors:  Andrew W Taylor; Darren Lee
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

7.  Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever.

Authors:  Q H Huang; M L Entwistle; J D Alvaro; R S Duman; V J Hruby; J B Tatro
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

8.  Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1.

Authors:  A Morimoto; N Murakami; T Nakamori; Y Sakata; T Watanabe
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

9.  Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages.

Authors:  Dayu Li; Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2008-04-03       Impact factor: 4.962

10.  The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.

Authors:  Andrew W Taylor; Nobuyoshi Kitaichi
Journal:  Brain Behav Immun       Date:  2008-01-02       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.